JP2021515791A5 - - Google Patents

Info

Publication number
JP2021515791A5
JP2021515791A5 JP2020548759A JP2020548759A JP2021515791A5 JP 2021515791 A5 JP2021515791 A5 JP 2021515791A5 JP 2020548759 A JP2020548759 A JP 2020548759A JP 2020548759 A JP2020548759 A JP 2020548759A JP 2021515791 A5 JP2021515791 A5 JP 2021515791A5
Authority
JP
Japan
Prior art keywords
treatment system
activator
transdermal treatment
silicone
transdermal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2020548759A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021515791A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2019/056025 external-priority patent/WO2019175106A1/en
Publication of JP2021515791A publication Critical patent/JP2021515791A/ja
Publication of JP2021515791A5 publication Critical patent/JP2021515791A5/ja
Abandoned legal-status Critical Current

Links

JP2020548759A 2018-03-13 2019-03-11 シリコーンアクリルハイブリッドポリマーを含む経皮治療システム Abandoned JP2021515791A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18161436.3 2018-03-13
EP18161436 2018-03-13
PCT/EP2019/056025 WO2019175106A1 (en) 2018-03-13 2019-03-11 Transdermal therapeutic system comprising a silicone acrylic hybrid polymer

Publications (2)

Publication Number Publication Date
JP2021515791A JP2021515791A (ja) 2021-06-24
JP2021515791A5 true JP2021515791A5 (cg-RX-API-DMAC7.html) 2022-03-16

Family

ID=61628188

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020548759A Abandoned JP2021515791A (ja) 2018-03-13 2019-03-11 シリコーンアクリルハイブリッドポリマーを含む経皮治療システム

Country Status (7)

Country Link
US (1) US20210008000A1 (cg-RX-API-DMAC7.html)
EP (1) EP3764997A1 (cg-RX-API-DMAC7.html)
JP (1) JP2021515791A (cg-RX-API-DMAC7.html)
CN (1) CN111971033A (cg-RX-API-DMAC7.html)
BR (1) BR112020018290A2 (cg-RX-API-DMAC7.html)
CA (1) CA3092752A1 (cg-RX-API-DMAC7.html)
WO (1) WO2019175106A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES3069698T3 (en) * 2023-09-28 2026-06-09 Lts Lohmann Therapie Systeme Ag Transdermal therapeutic system comprising cytisine

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5362496A (en) * 1993-08-04 1994-11-08 Pharmetrix Corporation Method and therapeutic system for smoking cessation
US6974588B1 (en) * 1999-12-07 2005-12-13 Elan Pharma International Limited Transdermal patch for delivering volatile liquid drugs
TWI389709B (zh) * 2005-12-01 2013-03-21 Novartis Ag 經皮治療系統
KR101432698B1 (ko) 2006-06-06 2014-08-22 다우 코닝 코포레이션 실리콘 아크릴레이트 하이브리드 조성물
RU2544702C2 (ru) 2009-04-24 2015-03-20 Хенкель Корпорейшн Клеи на основе силикон-акрилового гибридного полимера
JP2013139554A (ja) * 2011-11-29 2013-07-18 Dow Corning Corp シリコーンアクリレートハイブリッド組成物及び該組成物の製造方法
EA201491164A1 (ru) 2011-12-12 2014-10-30 ЭлТиЭс ЛОМАНН ТЕРАПИ-ЗЮСТЕМ АГ Трансдермальная система доставки
AU2013205080B2 (en) * 2012-12-12 2016-07-07 Lts Lohmann Therapie-Systeme Ag Transdermal Delivery System
KR102048682B1 (ko) 2015-02-09 2019-11-27 다우 실리콘즈 코포레이션 다중상 실리콘 아크릴 하이브리드 점탄성 조성물 및 이의 제조 방법
US20170112781A1 (en) * 2015-10-27 2017-04-27 Noven Pharmaceuticals, Inc. Transdermal drug delivery systems with polyisobutylene face adhesive
WO2018015424A1 (en) * 2016-07-22 2018-01-25 Lts Lohmann Therapie-Systeme Ag Control of adhesive domains

Similar Documents

Publication Publication Date Title
EP0062682B1 (en) Adhesive preparation for heart disease and process for its preparation
AU2016215180B2 (en) Pressure-sensitive adhesives for transdermal drug delivery
CN1705472A (zh) 吸水性和粘附性能改善的经皮给药系统
JPH0474329B2 (cg-RX-API-DMAC7.html)
US5458885A (en) Basic active component-permeable pressure sensitive adhesive polymer material process of the production thereof and use thereof
US5260064A (en) Percutaneous-administration-type pharmaceutical preparation of nitroglycerin
JPH0725669B2 (ja) 経皮投与用医薬製剤
JP3361674B2 (ja) 医療用粘着剤組成物
JP2021515789A5 (cg-RX-API-DMAC7.html)
JP2021517572A5 (cg-RX-API-DMAC7.html)
JP2967788B2 (ja) 医療用粘着テープおよび疾患治療用テープ製剤
JP2024532418A5 (cg-RX-API-DMAC7.html)
JP2021522187A5 (cg-RX-API-DMAC7.html)
JP2021517569A5 (cg-RX-API-DMAC7.html)
JP4988079B2 (ja) 経皮吸収型製剤
JP2022554147A5 (cg-RX-API-DMAC7.html)
JPS6066759A (ja) 医薬製剤
JP4255536B2 (ja) 新規貼付剤
JP3676567B2 (ja) 医療用粘着剤組成物及び医療用貼付剤
JP3046330B2 (ja) 貼付製剤
JP3233705B2 (ja) 貼付剤
JP2697191B2 (ja) 経皮吸収製剤
JPS62263120A (ja) 貼付剤
JPS5835113A (ja) 複合製剤
JPH06239753A (ja) 抗血栓経皮吸収製剤